Zabeer Bhatti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zabeer Bhatti has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Amit Dhamoon
State University of New York Upstate Medical University, 750 E. Adams Street Syracuse, NY 13210, USA
1 shared publication- Amit Dhamoon
Internal Medicine, State University of New York Upstate Medical University, Syracuse, USA
1 shared publication - Dalvir Gill
Department of Internal Medicine, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
1 shared publication Fatme Allam
Department of Rheumatology, SUNY Upstate Medical University, Syracuse, NY
1 shared publicationJaswinder Virk
Department of Internal Medicine, SUNY Upstate Medical University, Syracuse, NY
1 shared publicationJessica Norsworthy
A Department of Medicine , State University of New York , Syracuse , NY , USA
1 shared publication
Latest Publications
- Open Access
- 21 June 2018
- Published by Wiley in Case Reports in Dermatological Medicine
- Vol. 2018, 1-3
Extensive Cutaneous Scalp Angiosarcoma
Angiosarcoma is a cancer that is derived from endothelial cells that line blood vessels and lymphatic channels. Cutaneous angiosarcoma can appear anywhere on the skin and the clinical presentation is highly variable. Most cases appear on the scalp and face de novo. Our case describes a 91-year-old female with cutaneous scalp angiosarcoma. Our case serves to remind physicians that an abnormal skin finding in older adults should raise their index of suspicion for angiosarcoma and an early biopsy should be performed.
- 21 June 2018
- Published by Wiley in Case Reports in Dermatological Medicine
- Vol. 2018, 1-3
Open AccessExtensive Cutaneous Scalp Angiosarcoma
Angiosarcoma is a cancer that is derived from endothelial cells that line blood vessels and lymphatic channels. Cutaneous angiosarcoma can appear anywhere on the skin and the clinical presentation is highly variable. Most cases appear on the scalp and face de novo. Our case describes a 91-year-old female with cutaneous scalp angiosarcoma. Our case serves to remind physicians that an abnormal skin finding in older adults should raise their index of suspicion for angiosarcoma and an early biopsy should be performed.
- 1 July 2017
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 35 (7) , 1034.e1-1034.e2
Fatal adenovirus infection in an immunocompetent host
- 1 July 2017
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 35 (7) , 1034.e1-1034.e2
Fatal adenovirus infection in an immunocompetent host
- Open Access
- 1 June 2017
- Published by Elsevier in The American Journal of Medicine
- Vol. 130 (6) , e249-e250
Screening of Celiac Disease in Patients With Sarcoidosis?
- 1 June 2017
- Published by Elsevier in The American Journal of Medicine
- Vol. 130 (6) , e249-e250
Open AccessScreening of Celiac Disease in Patients With Sarcoidosis?
- 28 March 2017
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 55 (7) , 659-661
Loperamide metabolite-induced cardiomyopathy and QTc prolongation
Loperamide is an over-the-counter, peripherally acting, μ-opioid receptor agonist used for the treatment of diarrhea. In recent times users have found that at higher doses, loperamide crosses the blood–brain barrier and reaches central μ-receptors in the brain, leading to central opiate effects including euphoria and respiratory depression. We report a case of a 37-year-old female who attempted suicide with over 200 loperamide tablets. During her overdose, her QTc was significantly prolonged at >600 ms. Our case aims to add to the growing body of literature describing life-threatening ventricular arrhythmias associated with loperamide toxicity and further suggests that a metabolite of loperamide, desmethylloperamide, may play a role in the pathogenesis.
- 28 March 2017
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 55 (7) , 659-661
Loperamide metabolite-induced cardiomyopathy and QTc prolongation
Loperamide is an over-the-counter, peripherally acting, μ-opioid receptor agonist used for the treatment of diarrhea. In recent times users have found that at higher doses, loperamide crosses the blood–brain barrier and reaches central μ-receptors in the brain, leading to central opiate effects including euphoria and respiratory depression. We report a case of a 37-year-old female who attempted suicide with over 200 loperamide tablets. During her overdose, her QTc was significantly prolonged at >600 ms. Our case aims to add to the growing body of literature describing life-threatening ventricular arrhythmias associated with loperamide toxicity and further suggests that a metabolite of loperamide, desmethylloperamide, may play a role in the pathogenesis.